05/20/2013
Interleukin Genetics, Inc. Announces Conference Call To Discuss First Quarter 2013 Results
05/20/2013
INTERLEUKIN GENETICS ANNOUNCES $12 MILLION PRIVATE PLACEMENT
05/14/2013
INTERLEUKIN GENETICS REPORTS FIRST QUARTER 2013 FINANCIAL RESULTS
03/28/2013
Interleukin Genetics Reports Fourth Quarter and Year End 2012 Results
03/21/2013
Interleukin Genetics, Inc. Announces Conference Call To Discuss Fourth Quarter 2012 Results
01/03/2013
Interleukin Genetics Appoints Scott Snyder as Chief Marketing Officer
11/14/2012
Interleukin Genetics Reports Third Quarter 2012 Financial Results
11/06/2012
Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2012 Results
08/23/2012
INTERLEUKIN GENETICS ANNOUNCES EXECUTIVE MANAGEMENT CHANGES
08/14/2012
Interleukin Genetics Reports Second Quarter 2012 Financial Results
08/06/2012
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS SECOND QUARTER 2012 RESULTS
05/10/2012
Interleukin Genetics Reports First Quarter 2012 Financial Results
05/02/2012
Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2012 Results
05/01/2012
Interleukin Genetics Launches iPhone® and iPad® App for Its Inherent Health® Services
03/29/2012
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2011 FINANCIAL RESULTS
03/28/2012
U-M SCHOOL OF DENTISTRY, INTERLEUKIN GENETICS COMPLETE ENROLLMENT OF NOVEL CLINICAL STUDY
03/22/2012
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FOURTH QUARTER 2011 RESULTS
02/08/2012
Interleukin Genetics, Inc. to Present at 14th Annual BIO CEO & Investor Conference
01/09/2012
Interleukin Genetics, Inc. to Present at Biotech Showcase™ 2012
12/14/2011
Interleukin Genetics Appoints Lynn Doucette-Stamm Vice President of Development
11/10/2011
Interleukin Genetics Reports Third Quarter 2011 Financial Results
11/03/2011
Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2011 Results
08/12/2011
Interleukin Genetics Reports Second Quarter 2011 Financial Results
08/04/2011
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS SECOND QUARTER 2011 RESULTS
05/12/2011
Interleukin Genetics Reports First Quarter 2011 Financial Results
05/10/2011
Interleukin Genetics and Metagenics Initiate Research Collaboration
05/05/2011
Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2011 Results
03/21/2011
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2010 FINANCIAL RESULTS
03/14/2011
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FOURTH QUARTER 2010 RESULTS
01/04/2011
Interleukin Genetics, Inc. to Present at Biotech Showcase 2011
11/11/2010
Interleukin Genetics Reports Third Quarter 2010 Financial Results
11/04/2010
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER 2010 RESULTS
08/16/2010
Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace
08/12/2010
Interleukin Genetics Reports Second Quarter 2010 Financial Results
08/12/2010
INTERLEUKIN GENETICS AND U OF MICHIGAN TO ASSESS PREDICTIVE VALUE OF NEW GENETIC TEST FOR PERIODONTA
08/05/2010
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS SECOND QUARTER 2010 RESULTS
06/25/2010
Interleukin Genetics, Inc. Receives Delisting Notification from NYSE Amex
05/13/2010
Interleukin Genetics Reports First Quarter 2010 Financial Results
05/06/2010
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FIRST QUARTER 2010 RESULTS
05/03/2010
INTERLEUKIN GENETICS TO PRESENT AT UPCOMING BIOTECH INDUSTRY MEETINGS
04/30/2010
Interleukin Genetics, Inc. Appoints William C. Mills to its Board of Directors
03/25/2010
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2009 FINANCIAL RESULTS
03/22/2010
NYSE AMEX PROVIDES INTERLEUKIN GENETICS, INC. EXTENSION TO MEET CONTINUED LISTING STANDARDS
03/18/2010
INTERLEUKIN GENETICS, INC. ANNOUNCES CONFERENCE CALL TO DISCUSS FOURTH QUARTER 2009 RESULTS
03/05/2010
Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
03/03/2010
INTERLEUKIN GENETICS, INC. AND STANFORD UNIVERSITY REPORT GENETIC TEST IMPROVES WEIGHT LOSS SUCCESS
02/05/2010
Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
01/19/2010
LABEC Pharma to Begin Selling Interleukin Genetics’ Heart Health Genetic Test in Europe
12/17/2009
Interleukin Genetics Launches Bone Health Genetic Test
12/07/2009
INTERLEUKIN GENETICS RECEIVES APPROVAL TO SELL ITS PST® PERIODONTAL DISEASE GENETIC TEST IN NEW YORK
12/02/2009
INTERLEUKIN GENETICS AND NYU LANGONE MEDICAL CENTER ANNOUNCE PUBLICATION OF STUDY ON GENETICS OF OA
11/12/2009
Interleukin Genetics Reports Third Quarter 2009 Financial Results
11/05/2009
INTERLEUKIN GENETICS ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER 2009 RESULTS
10/29/2009
Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand
10/13/2009
Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
09/23/2009
Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test’s
08/13/2009
Interleukin Genetics Reports Second Quarter 2009 Financial Results
08/06/2009
Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
07/02/2009
Interleukin Genetics Announces Strategic Divestment of Alan James Group
06/08/2009
Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at ADA Meeting
06/08/2009
Interleukin Genetics Launches Inherent Health Brand
05/14/2009
Interleukin Genetics Reports First Quarter 2009 Financial Results
05/14/2009
NYSE Amex Accepts Interleukin Genetics’ Plan to Meet Continued Listing Standards
05/12/2009
Interleukin Genetics to Chair Expert Panel Discussion on BioMarker Use in Drug Development at BIO
05/07/2009
INTERLEUKIN GENETICS ANNOUNCES CONFERENCE CALL TO DISCUSS FIRST QUARTER 2009 RESULTS
04/06/2009
ILI Grants LABEC Pharma a License for Sales & Distribution of Heart Health Genetic Test
04/01/2009
INTERLEUKIN GENETICS PRESENTS RESEARCH LINKING VERTEBRAL FRACTURES TO GENE VARIATIONS IN ASIAN WOMEN
03/30/2009
Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Panel
03/17/2009
Improved Genetic Test Product Empowers Individuals Better Understand Their Unique Nutritional Needs
03/09/2009
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2008 FINANCIAL RESULTS
02/27/2009
INTERLEUKIN GENETICS ANNOUNCES CONFERENCE CALL TO DISCUSS FOURTH QUARTER 2008 RESULTS
02/02/2009
INTERLEUKIN GENETICS TO PRESENT AT G-2 REPORTS’ MOLECULAR DIAGNOSTIC CONFERENCE
01/27/2009
Interleukin Genetics' Submits Plan To Regain Compliance with Continued Listing Standards
01/23/2009
INTERLEUKIN GENETICS TO PRESENT DATA HIGHLIGHTING LINK BETWEEN INFLAMMATORY GENE VARIATIONS AND LESS
12/26/2008
Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Std Section 1003(a)
12/05/2008
Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
11/17/2008
Heart Health Genetic Test a Tool for Identifying Patients with Heart Attack Risk
11/13/2008
INTERLEUKIN GENETICS REPORTS THIRD QUARTER 2008 FINANCIAL RESULTS
11/11/2008
Interleukin Genetics to Present New Findings on Osteoporosis at American Society of Human Genetics
11/06/2008
Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Results
11/03/2008
Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
10/30/2008
Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis
09/18/2008
Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
09/15/2008
Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
09/12/2008
Interleukin Genetics Wins International Award - Outstanding Research Published in Journal Nutrition
09/04/2008
Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
08/21/2008
Alan James Group Launches Enhanced Websites for Existing Nutritional Supplement Product Line
08/13/2008
Interleukin Genetics Licenses its PST® Genetic Test to OralDNA Labs
08/13/2008
INTERLEUKIN GENETICS REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS
08/06/2008
Interleukin Genetics Announces Conference Call and Webcast to Discuss 2Q 2008 Business Results
08/05/2008
Interleukin Genetics Appoints Partha P. Paul, Ph.D., as Senior Director, Business Development
07/28/2008
Interleukin Genetics Expands its Board of Directors
07/22/2008
Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
06/10/2008
Interleukin Genetics to Present at 2008 BIO International Convention
06/03/2008
Interleukin Genetics to Present at the 13th International Conference on Periodontal Research
05/21/2008
Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
05/14/2008
INTERLEUKIN GENETICS REPORTS FIRST QUARTER 2008 FINANCIAL RESULTS
05/13/2008
Interleukin Genetics to Present at Rodman & Renshaw
05/07/2008
Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Results
05/01/2008
The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics’ Heart Health Test
04/30/2008
Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
03/27/2008
INTERLEUKIN GENETICS REPORTS FOURTH QUARTER AND YEAR END 2007 FINANCIAL RESULTS
03/18/2008
Interleukin Genetics Retains Top Life Science Communications Firms
02/28/2008
Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
01/28/2008
INTERLEUKIN GENETICS INC. MANAGEMENT TO PRESENT AT HEALTHCARE CONFERENCES
01/23/2008
INTERLEUKIN GENETICS APPOINTS LEWIS H. BENDER AS CHIEF EXECUTIVE OFFICER
12/19/2007
Interleukin Genetics Annouces Conversion Of $2.04 Million of Debt into Common Stock
11/07/2007
Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
11/01/2007
Interleukin Genetics Enhances Focus on Key Growth Areas Related to Obesity and Gastric Cancer
09/25/2007
Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
09/06/2007
INTERLEUKIN GENETICS ANNOUNCES MANAGEMENT AND BOARD APPOINTMENTS
08/16/2007
INTERLEUKIN INITIATES STUDY OF GENETICS OF OSTEOARTHRITIS WITH NYU
08/09/2007
Interleukin Genetics Reports Second Quarter 2007 Financial Results
07/24/2007
INTERLEUKIN INITIATES PROGRAM TO DEVELOP GENETIC TEST TO GUIDE MORE EFFECTIVE WEIGHT CONTROL
07/16/2007
INTERLEUKIN GENETICS COMPLETES ENROLLMENT OF STUDIES IN JAPAN AND CHINA ON GENETIC RISK
07/03/2007
INTERLEUKIN GENETICS ANNOUNCES EXECUTIVE MANAGEMENT
05/09/2007
Interleukin Genetics Reports First Quarter 2007 Financial Results
05/03/2007
Interleukin Genetics to Host First Quarter 2007 Financial Results Conference Call On May 9
04/09/2007
Interleukin To Hold Investor Meeting On June 12 Following Annual Meeting
04/02/2007
Interleukin Genetics Reports 2006 Year-End and Fourth Quarter Financial Results
03/31/2007
Interleukin Genetics to Host Fourth Quarter and Fiscal 2006 Financial Results Conference Call Apr. 2
03/30/2007
Interleukin Genetics Expands Research Collaboration with Alticor
03/27/2007
ACC Presentation Indicates IL-1 Gene Variants Determine Increased Risk for Coronary Artery Disease
03/15/2007
Interleukin Genetics Postpones Fourth Quarter And Fiscal 2006 Financial Results Conference Call
11/08/2006
Interleukin Genetics Reports Third Quarter Financial Results
11/03/2006
Interleukin Genetics To Host Third Quarter 2006 Financial Results Conference Call On November 8
11/02/2006
Interleukin Genetics Sponsors Expert Meeting On The Role Of Inflammation In Aging
09/07/2006
Interleukin Genetics Initiates Study Of IL-1 Gene Variation And Osteoporosis In Korean Women
08/17/2006
Interleukin Genetics Acquires Alan James Group and Secures $30 Million in New Financing
08/09/2006
Interleukin Genetics Reports Second Quarter Financial Results
07/05/2006
Interleukin Genetics CEO Presents at Opening Session of EuroPerio 5 Meeting
06/28/2006
Interleukin Genetics Expands DNA Analysis Lab Operations to Meet Demand for Risk Assessment Tests
06/21/2006
Interleukin Genetics Licenses DNA-Based Weight Management Technology From GeneOb
06/19/2006
Interleukin Genetics Initiates Study Of IL-1 Variations and Incidence Of Early Stroke In Italian Pop
06/14/2006
ILI Reports On Annual Stockholder Meeting And Announces New Director
05/16/2006
Interleukin Genetics CEO to present at Korean Conference on Aging
05/12/2006
Dr. Philip Reilly elected to Board of Trustees at Cornell University
05/09/2006
Interleukin Genetics Reports First Quarter Financial Results
03/31/2006
Interleukin Genetics Announces Changes in Executive Management
03/14/2006
Interleukin Genetics Reports Fourth Quarter And Year-End Financial Results
02/28/2006
Interleukin Genetics Enters Into New Agreements and Amends Agreements with Alticor
01/11/2006
Research on genetic variation and inflammation..
12/28/2005
Interleukin Genetics on the American Stock Exchange...
11/04/2005
Interleukin Genetics Reports Third Quarter Financial Results
08/03/2005
Interleukin Genetics Reports Second Quarter Financial Results
07/26/2005
Interleukin Genetics Announces Changes in Senior Management
07/11/2005
Interleukin Genetics Names Ramon W. Mohanlal, M.D. as Chief Medical Officer
07/07/2005
Interleukin Genetics Regains Compliance with OTCBB Requirements
06/30/2005
Interleukin Genetics Files Form 10-K/A For Fiscal Year 2004
06/16/2005
Interleukin Genetics NASD Hearing Rescheduled
06/13/2005
Interleukin Genetics Appeals NASD Determination
05/05/2005
Interleukin Genetics Reports First Quarter Financial Results
04/26/2005
Interleukin Genetics Restates Its 2003 and 2004 Financial Statements
04/25/2005
Interleukin Achieves Milestone and Receives $2 Million Pre-payment
04/07/2005
Interleukin Genetics Updates Status of Filing Annual Report on Form 10-K ...
04/01/2005
Interleukin Genetics Announces Delay in filing Annual Report on Form 10-K ...
03/16/2005
Interleukin Genetics Reports Fourth Quarter and Year-End Results
03/03/2005
Interleukin Genetics extends Research Collaboration, Modifies Stock Purchase and Product ...
  |